Latest Financial Results News

Hydrix Limited reports steady June quarter revenues with a 10% rise from the prior quarter, supported by new contract wins and a robust $40 million project pipeline.

betr Entertainment Limited has boosted its all-scrip takeover offer for PointsBet while reporting a strong Q4 FY25 with $70 million EBITDA profit, underpinned by robust growth and strategic integrations.

Airtasker Limited has reported its second consecutive year of positive free cash flow alongside robust revenue growth, fueling accelerated expansion in the UK and US marketplaces.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

hummgroup has agreed to limited due diligence with The Abercrombie Group following a $0.58 per share non-binding proposal, aiming to clarify a potential binding offer by mid-September.

Airtasker Limited reports its second consecutive year of positive free cash flow alongside a 29% jump in marketplaces revenue, driven by explosive growth in the UK and US markets.

MedAdvisor reports a significant revenue decline in FY25 amid US program delays but strengthens its balance sheet through a capital raise and ANZ business sale. The company signals a strategic pivot with potential US business divestment on the horizon.

Pointerra Limited reported strong FY25 Q4 results marked by new enterprise customers, a major US defense subcontract, and significant cashflow improvements. The company’s AI-enhanced digital twin platform is gaining traction across multiple sectors, setting the stage for growth in FY26.

Decidr AI Industries reported an 82% revenue jump in its AI platform during Q4 FY25, launched AI Mentors with The Growth Faculty, and divested its 13Seeds business to sharpen focus on AI innovation.

Doctor Care Anywhere has reported a landmark positive operating and investing cash inflow in Q2 2025, alongside modest consultation growth and strategic service expansion. The company reiterates its ambitious revenue and profitability targets amid ongoing cost transformation.

Osteopore Limited has posted a record AUD 835K revenue in Q2 CY25, driven by strong APAC sales and new European market access following EU MDR clearance. The company also advances clinical trials and refreshes key distribution channels.

MONEYME has exceeded its FY25 operating cash profit expectations by 20%, driven by robust loan book expansion and improved credit quality, while gearing up for a major credit card launch.